Navigation Links
Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
Date:11/14/2007

>

-- Initiation of a program to evaluate RDEA119 in inflammatory diseases;

and

-- Assessing a next-generation MEK inhibitor from our follow-on program in

a first-in-human micro-dosing study.

On September 30, 2007, Ardea had a total of $35.6 million in cash, cash equivalents and short-term investments. Based on current projections, the Company expects cash, cash equivalents, and short-term investments on December 31, 2007 to be approximately $28 million. The Company expects its current cash resources to fund operations through 2008. These projections exclude the potential impact of any future business development or financing activity.

Approximately 11.8 million common equivalent shares were issued and outstanding on September 30, 2007, including 1.6 million common shares underlying outstanding convertible preferred stock.

About Ardea Biosciences, Inc.

Ardea Biosciences is focused on the discovery and development of small-molecule therapeutics for the treatment of viral diseases, cancer and inflammatory diseases. The Company plans to initiate clinical studies on four compounds this year. These include RDEA806, the Company's lead non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV, which recently completed Phase 1 clinical trials, RDEA119, a mitogen-activated ERK kinase (MEK) inhibitor for the treatment of cancer and inflammatory diseases, which has been cleared by the FDA to enter Phase 1 clinical trials, and a follow-on NNRTI and a follow-on MEK inhibitor, both of which are scheduled to enter first-in-human studies in the fourth quarter of 2007.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such for
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Ardea Biosciences Announces Changes to Research Management
3. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
4. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
5. Pressure BioSciences, Inc. Issued First Patent in Canada
6. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
7. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
8. Pressure BioSciences, Inc. Provides Corporate Update
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. QMed, Inc. Reports July Medicare SNP Enrollments
11. Phlo Affiliate Reports Expanded Coverage to Oregon Border
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... LONDON, Dec. 15 Thomson ... Pharma ® has become the first drug pipeline ... and outcome information. This highly anticipated new content ... this month. ,, Thomson Pharma ... from registries, publications, press releases, conferences, and other ...
(Date:12/15/2009)... The Prinz Law Office has announced the launch of ... businesses secure legal services in the current economic climate. ... them the opportunity to finance legal services over a ... requiring any equity in their start-up companies. The ... for fixed montly payment arrangements over 6 to 12 ...
(Date:12/14/2009)... Vermillion, Inc. (Pink Sheets: VRML), ... C. Wallen, Ph.D. Chief Scientific Officer, Senior ... Laboratories, will be joining its board of ... ,, "Bill brings more than 20 ... and biotechnology," said Gail Page, Vermillion Executive ...
(Date:12/14/2009)... Joins with State Biotech Leaders to Develop ... and Development while Boosting Rhode Island,s Growing ... PROVIDENCE, R.I., Dec. 14 Several ... research, medicine and biotechnology gathered today at ... the importance of medical innovation in Rhode ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4
... , announced today they have signed a distribution ... independent distributor of advanced clinical in-vitro diagnostic products. ... last Wednesday with Promega. , ,"Both companies share ... provide strong long-term customer value. Inter Medico's highly ...
... faculty at the University of Wisconsin-Eau Claire are ... to work on research relating to materials science ... to assist local industries. , ,UW-Eau Claires newly ... collaboration among science faculty across disciplines, promote interactions ...
... economists in the Unites States are concerned with the increasing ... down and begin the process of leveling the playing field. ... , ,As developing nations rush to play catch-up with more ... to friends in high places, and not necessarily for sound ...
Other Biology Technology:UW-Eau Claire creates Materials Science Center 2UW-Eau Claire creates Materials Science Center 3How do you level the playing field with China? 2How do you level the playing field with China? 3
(Date:12/14/2009)... December 10, 2009If you are spending the holidays with ... whether you would be better off with another family, ... , A research team from McMaster University and the ... cichlids, a species that lives in groups, members make ... results appear in the current issue of Biology ...
(Date:12/14/2009)... thought of tool use as a defining feature of humans. ... primates, along with birds and an array of other mammals. ... Current Biology , a Cell Press publication, adds an octopus ... octopus under study manages a behavioral trick that the researchers ... over stacked, upright coconut shell "bowls," makes its eight arms ...
(Date:12/14/2009)... 14 MODA Technology Partners, a global ... and product testing for the Pharmaceutical industry, today ... company,s third generation mobile data acquisition platform. The ... further automate their regulated manufacturing processes. ,, ... Fully-Configurable Test Methods: Each test ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Immunotherapy Demonstrates Long Term Success in Treating Lymphoma 60471 1Immunotherapy Demonstrates Long Term Success in Treating Lymphoma 60471 2Immunotherapy Demonstrates Long Term Success in Treating Lymphoma 60471 3Immunotherapy Demonstrates Long Term Success in Treating Lymphoma 60471 4Carmel Pharma Introduces PhaSeal Secondary Set 28C60 29 60467 1Carmel Pharma Introduces PhaSeal Secondary Set 28C60 29 60467 2Study shows that sleep disturbances improve after retirement 60463 1Study shows that sleep disturbances improve after retirement 60463 2Study shows that sleep disturbances improve after retirement 60463 3Study shows that sleep disturbances improve after retirement 60463 4Study shows that sleep disturbances improve after retirement 60463 5
... Maryland officials can reduce electricity use in the ... Greenhouse Gas Initiative (RGGI) cap-and-trade auctions in energy ... University of Maryland-led research team. It adds that ... might range from direct subsidies helping consumers or ...
... Center is seeing a large number of leptospirosis cases in California ... when and why the sea lions contract this disease. Every ... number of sea lions admitted as a result of this bacterial ... The current research will focus on the factors contributing to ...
... National Jewish Health are testing an investigational treatment to ... patients can immediately help them breathe more easily. Destruction ... stiff and overinflated with air that cannot escape. The ... minimally invasive procedure, could relieve the hyperinflation of the ...
Other Biology News:Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 2Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 3Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 4Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 5The Marine Mammal Center begins new leptospirosis study in California 2Researchers at National Jewish Health evaluating a treatment 2
Goat anti-mouse gamma chain-HRP...
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
In plasmid or lambda vector. Please inquire for more details!...
Biology Products: